Anil Chandraker, MD
Brigham and Women's Hospital · Brigham and Women's Hospital/Harvard
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anil Chandraker, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:35 UTC. Open this list on ClinicalTrials.gov
- N/ANCT01516177 · Associating Renal Transplantation With the ITN Signature of ToleranceNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Kidney Transplantation · study chair
- Ph4NCT01437943 · Effect of Short Term Aliskiren Treatment in Kidney Transplant PatientsBrigham and Women's Hospital · terminated · Kidney Disease, Kidney Failure, Chronic · principal investigator
- Ph2NCT01278745 · Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac TransplantationNational Institute of Allergy and Infectious Diseases (NIAID) · terminated · Cardiac Allograft Vasculopathy, Heart Transplant Recipients · study chair
- Ph4NCT01034176 · BK Treatment StudyBrigham and Women's Hospital · completed · BK Viremia · principal investigator
- Ph2NCT00307125 · Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA AlloantibodiesNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Kidney Transplant, Kidney Transplant Recipient, Graft Function/Survival · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.